Precigen's Strong Second Quarter Signals Significant Growth, Validates AdenoVerse Platform; PRGN-2009 Advances in HPV-Driven Cancers Life Science Investing
Gain Therapeutics to Participate at H.C. Wainwright 28th Annual Global Investment Conference Life Science Investing
Ivonescimab Plus Chemotherapy Global Phase III HARMONi Primary Analysis Results Published in The Lancet Oncology Life Science Investing
FDA approves IMAAVY® as first-ever treatment for warm autoimmune hemolytic anemia , representing a landmark advancement for patients Pharmaceutical Investing
DehydraTECH-enhanced Amycretin and Retatrutide Yield Significant Absorption Improvements in Lexaria's 2026 Animal Study #2 Biotech Investing
DehydraTECH-enhanced Amycretin and Retatrutide Yield Significant Absorption Improvements in Lexaria's 2026 Animal Study #2 Biotech Investing
Ocumetics Announces Completion of Third and Final Tranche of Unit Private Placement Medical Device Investing
LEQEMBI IQLIK® Autoinjector for Initiation of Therapy Now Available in the U.S. for Early Alzheimer's Disease Life Science Investing
